| Previous close | 3.8200 |
| Open | 3.8000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 27.50 |
| Expiry date | 2025-12-19 |
| Day's range | 3.6500 - 3.8200 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
ZacksPfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksGSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
GSK's Arexvy becomes the first RSV vaccine approved for adults aged 50-59 who are at high risk.
© 2024 Yahoo. All rights reserved.